NCT00426049View on ClinicalTrials.gov

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

PHASE3UnknownINTERVENTIONAL
Enrollment

484

Participants

Timeline

Start Date

October 31, 2006

Conditions
Coronary Artery DiseaseCoronary Restenosis
Interventions
DRUG

Everolimus

Trial Locations (1)

13353

RECRUITING

German Heart Institute Berlin, Berlin

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

German Heart Institute

OTHER

NCT00426049 - Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation | Biotech Hunter | Biotech Hunter